HCPCS Level II J7683: Triamcinolone Inhalation Solution, Compounded
HCPCS Level II code J7683 describes a compounded triamcinolone inhalation solution in a concentrated form billed per milligram, used as an inhaled corticosteroid formulation administered through durable medical equipment; the service type is a compounded inhalation medication dispensed/administrated via DME and the typical site of service is outpatient or home-based respiratory therapy where nebulizer or inhalation devices are provided.
For related coverage guidance, see recent payer policy updates: Bendamustine Products Coverage Criteria, T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and Romidepsin, Brentuximab Vedotin (Adcetris®) Coverage Criteria.
Customize your policy alerts
Sign up for hcpcs J7683 policy alerts
Get alerted when payer policies referencing J7683 are released or updated.
Monitor payer policy activity